Sort
8,912 grants matching “sars cov 2”
FY21 ITCA NARCH XI
$1,216,518Maria Dadgar · Inter Tribal Council Of Arizona, Inc. · S06 · FY2023 · GM
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,215,514Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
NHLBI RECOVER Cybersecurity Program
$1,214,646 · N02 · FY2025 · HL
Specific Pathogen Free 18 Baboon Research Resource {(SPF18BRR): Resource Core
$1,214,096Joe H. Simmons · University Of Tx Md Anderson Can Ctr · P40 · FY2024 · OD
Specific Pathogen Free 18 Baboon Research Resource {(SPF18BRR): Resource Core
$1,214,094Joe H. Simmons · University Of Tx Md Anderson Can Ctr · P40 · FY2023 · OD
Specific Pathogen Free 18 Baboon Research Resource {(SPF18BRR): Resource Core
$1,214,094William D Hopkins · University Of Tx Md Anderson Can Ctr · P40 · FY2025 · OD
Prevention of Substance Use in At-risk Students: A Family-centered Web Program
$1,213,204Elizabeth A Stormshak · University Of Oregon · R01 · FY2021 · DA
Targeting CD180 to induce anti-KSHV response in nonhuman primates
$1,212,634Scott W Wong · Oregon Health & Science University · U01 · FY2024 · CA
REPRIEVE COVID-19 Administrative Supplement
$1,210,912Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2020 · HL
REPRIEVE - CCC - Lead Application
$1,210,912Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2021 · HL
Membrane Remodeling in Viral Infection and Viral Assembly
$1,210,393Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$1,209,546Andrea L Cox · Johns Hopkins University · U19 · FY2022 · AI
Sex, obesity, immunometabolism, and viral persistence in post-acute sequelae of SARS-CoV-2 infection
$1,209,546Andrea L Cox · Johns Hopkins University · U19 · FY2022 · AI
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
$1,209,450Rudolph L Leibel · Columbia University Health Sciences · UH3 · FY2024 · DK
Vasculitis and Translational Medicine
$1,207,231Peter Grayson · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Sin Duda: a community-driven approach to expand reach, access and uptake of COVID-19 home-based tests for at risk Latinos
$1,206,425Kathleen R Page · Johns Hopkins University · U01 · FY2023 · MD
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2
$1,206,220Michael S. Diamond · Washington University · R01 · FY2021 · AI
FY21 ITCA NARCH XI
$1,205,776Maria Dadgar · Inter Tribal Council Of Arizona, Inc. · S06 · FY2024 · GM
Immune response to COVID-19 vaccination in individuals with immune disorders
$1,205,774Emily Ricotta · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2
$1,202,440Michael S. Diamond · Washington University · R01 · FY2022 · AI
New Jersey Alliance for Clinical Translational Science: NJ ACTS
$1,200,946Reynold Alexander Panettieri · Rutgers Biomedical/Health Sciences-Rbhs · UL1 · FY2021 · TR
University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC)
$1,200,881Jay Steven Magaziner · University Of Maryland Baltimore · P30 · FY2024 · AG
Using the multiphase optimization strategy (MOST) to optimize an intervention to increase COVID-19 testing for Black and Latino/Hispanic frontline essential workers
$1,200,348Marya Gwadz · New York University · U01 · FY2022 · MD
Development of high-performance low field MRI technology
$1,200,323Adrienne Campbell · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Studies of the SARS-CoV-2 Spike Protein
$1,200,057Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA